Latest Continuous Disclosure News

Leeuwin Metals Ltd has addressed a sudden spike in its share price and trading volume, confirming no undisclosed material information exists and attributing the movement to external market factors and a new research report.

Hudson Investment Group faces intense scrutiny from ASX after its auditor issued a Disclaimer of Opinion on the 2024 financial report, citing doubts over a $2.4 million property receivable and the company’s going concern status.

Alterity Therapeutics faces ASX scrutiny after mistakenly marking multiple announcements as market sensitive, prompting a review of its disclosure practices. The biotech denies any intent to manipulate its share price despite repeated errors.

The Lederer Group has made an unsolicited off-market takeover offer for Elanor Commercial Property Fund at 70 cents per security, prompting the Fund's board to carefully consider its response.

Unith Ltd has acknowledged a technical breach of its trading policy following a director's share purchase during a closed period, prompting a comprehensive review of its governance framework.

X2M Connect Limited’s X2MO securities have been suspended from ASX trading due to non-compliance with listing rules, raising questions about the company’s regulatory standing and next steps.

DigitalX Limited has responded to a detailed ASX query regarding its Solana staking yields, exclusive validator agreements, and governance disclosures involving key personnel. The company defends its commercial decisions and compliance amid scrutiny over related party transactions and securities trading.

Dragon Mountain Gold Limited has responded to an ASX price query following a sharp share price increase, denying any undisclosed information and confirming compliance with continuous disclosure rules.

Classic Minerals Limited has secured strategic tenements adjoining its Forrestania Gold Project and appointed a drilling contractor under a novel drill-for-equity agreement, while navigating ongoing legal disputes and ASX suspension.

PPK Group has dismissed any undisclosed information behind its recent share price surge, revealing instead that acquisition talks over its Craig International Ballistics stake have been terminated.

Botanix Pharmaceuticals confirms material sales and prescription growth data, explaining the timing of its ASX disclosures amid share price fluctuations.

Cobre Limited’s CBEO securities have been suspended from trading pending regulatory compliance, raising questions about the company’s next steps and investor impact.